Saudi Food and Drug Authority - Regulatory authority for pharmaceuticals and medical devices in Saudi Arabia
显示 2024 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| Bylvay | PATHEON FRANCE | Capsule, hard | Jan 1, 2024 | NCE |
| Bylvay | PATHEON FRANCE | Capsule, hard | Jan 1, 2024 | NCE |
| Etalon 0.25 mg per 5 ml | ANFARM HELLAS S.A | Solution for injection | Jan 1, 2024 | Generic |
| Idelvion | CSL BEHRING | Powder and solvent for solution for injection | Jan 1, 2024 | Biological |
| Calquence | AstraZeneca AB | Film-coated tablet | Jan 1, 2024 | NCE |
| Propofol - Lipuro 1000 mg per 50 ml | B. BRAUN MELSUNGEN AG | Emulsion for injection/infusion | Jan 1, 2024 | Generic |
| Idelvion | CSL BEHRING | Powder and solvent for solution for injection | Jan 1, 2024 | Biological |
| Jemperli | AJINOMOTO ALTHEA INCORPORATED | Concentrate for solution for infusion | Jan 1, 2024 | Biological |
| Idelvion | CSL BEHRING | Powder and solvent for solution for injection | Jan 1, 2024 | Biological |
| Idelvion | CSL BEHRING | Powder and solvent for solution for injection | Jan 1, 2024 | Biological |
| KRABEVA 400 mg per 16 ml | Biocon Limited | Concentrate for solution for infusion | Jan 1, 2024 | Biological |
| Idelvion | CSL BEHRING | Powder and solvent for solution for injection | Jan 1, 2024 | Biological |
| Lornoxicam- GPI | Global Pharmaceutical Industries | Powder and solvent for solution for injection | Jan 1, 2024 | Generic |
| Camzyos | PATHEON INC | Capsule, hard | Jan 1, 2024 | NCE |
| KRABEVA 100 per 4 ml | Biocon Limited | Concentrate for solution for infusion | Jan 1, 2024 | Biological |
| Ataben | Hetero Labs Limited Unit – III | Capsule, hard | Jan 1, 2024 | Generic |
| Camzyos | PATHEON INC | Capsule, hard | Jan 1, 2024 | NCE |
| Camzyos | PATHEON INC | Capsule, hard | Jan 1, 2024 | NCE |
| Rivaroxaban MCP | Med city | Film-coated tablet | Jan 1, 2024 | Generic |
| Sedafol | ASPIRO PHARMA LIMITED | Emulsion for infusion | Jan 1, 2024 | Generic |
